Allergy Therapeutics

📍 Worthing, United Kingdom🗓 Founded 1998👥 369 employees💰 Last funded Jan 2011
Pharmaceutical Manufacturing🌐 allergytherapeutics.com
Website LinkedIn
Allergy Therapeutics is a visionary immunology business with specialist experience in the research and development of allergy treatments. We have a well-established commercial presence in Europe and are focused on the US market. We specialise in the diagnosis and treatment of allergy. We mainly sell our products in European countries and our pipeline of products in clinical development includes vaccines for grass, tree and house dust mite, as well as a peanut allergy vaccine in pre-clinical development. Adjuvant systems to boost performance of vaccines outside of allergy are also under evaluation.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
1998
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Allergy Therapeutics?
Allergy Therapeutics has 1 investors on record on gritt.io.
When did Allergy Therapeutics last raise funding?
The most recent investment in Allergy Therapeutics recorded on gritt.io was in January 2011.
When was Allergy Therapeutics founded?
Allergy Therapeutics was founded in 1998.
What industry is Allergy Therapeutics in?
Allergy Therapeutics operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is Allergy Therapeutics based?
Allergy Therapeutics is headquartered in Worthing, United Kingdom.